Candriam is launching an oncology impact fund on 4 February, investing in listed companies that develop products and services for the treatment of cancer.
The Candriam Equities L Oncology Impact fund will focus on combatting the cancer epidemic and is being rolled out to coincide with World Cancer Day. European asset manager Candriam, which runs €3bn across biotech, robotics and demographic strategies, said the launch is in response to global ageing, which is fuelling the cancer epidemic, with worldwide cancer deaths projected to increase by 60% from 8 million to 13 million by the year 2030. Candriam's Van de Maele: Self-indexing too complex from regulatory standpoint The fund aims to identify the breakthrough innovations set to ch...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
